Nanobiotix S.A. (NBTX) Balance Sheet

NASDAQ: NBTXAssets, liabilities, debt and equity over 10 years.

NBTX balance sheet, 2025

December 31, 2025 · euros

€67.8M assets = €152.2M liabilities + −€84.5M equity

What it owns€67.8MCash & ST investments: €52.8M (77.8%)Cash & ST investments€52.8M · 78%Receivables: €7.7M (11.3%)Other current: €2.3M (3.4%)PP&E: €4.6M (6.7%)Goodwill & intangibles: €10,000 (0.0%)Other non-current: €434,000 (0.6%)=How it is financed€152.2MCurrent liabilities: €57.5M (37.8%)Current liabilities€57.5M · 38%Long-term debt: €89.1M (58.5%)Long-term debt€89.1M · 59%Other LT liabilities: €5.6M (3.7%)

Liabilities exceed assets: shareholders’ equity is negative (−€84.5M).

Both columns are drawn to the same scale: what NBTX owns equals what it owes plus shareholders’ equity. Hover a block for its value.

NBTX financial health

Current ratio1.09
Adequate · current assets cover current liabilities 1.09×
Equity / assets−124.7%
Thin equity · of assets funded by shareholders
Cash / debt55.3%
Partial cover · cash & short-term investments vs total debt
Goodwill & intangibles0.0%
Mostly tangible · of total assets

Descriptive bands, not a rating. Fiscal 2025.

NBTX balance sheet trends, 2016–2025

MetricTrendThenLatestChange
Total assets€30.4M2016€67.8M2025+9.3%/yr
Total liabilities€13.0M2016€152.2M2025+31.4%/yr
Shareholders’ equity€17.4M2016−€84.5M2025—
Cash & short-term investments€21.1M2016€52.8M2025+10.7%/yr
Total debt€5.7M2016€95.3M2025+36.8%/yr
Net cash (debt)€15.4M2016−€42.6M2025−€58.0M
Working capital€18.6M2016€5.2M2025−€13.4M
Current ratio3.2620161.092025−2.17
Debt / equity0.3320161.722021+1.39
Shares outstanding15.3M201647.8M2025+13.5%/yr

Change is the average annual growth (CAGR) or the difference between the first and latest year.

NBTX assets

Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current

NBTX liabilities and equity

Current liabilitiesLong-term debtOther long-term liabilitiesEquity

NBTX debt vs cash

Total debtCash & ST investmentsNet cash (debt)

Debt includes short- and long-term borrowings and, where reported, lease obligations.

NBTX balance sheet in euros

2025202420232022202120202019201820172016
Assets
Cash & short-term investments€52.8M€49.7M€75.3M€41.4M€84.2M€119.2M€35.1M€36.2M€47.2M€21.1M
Cash & equivalents€52.8M€49.7M€75.3M€41.4M€83.9M€119.2M€35.1M€36.2M€47.2M€21.1M
Short-term investments———€2.8M——————
Receivables€7.7M€8.5M€3.0M€2.8M€3.9M€3.9M€1.3M€997,000€844,000€5,207
Inventory€0€0€200,000€3.0M−€3.0M−€40.3M€2.7M€1.1M−€4.9M−€5.0M
Other current assets€2.3M€3.2M€8.9M€5.1M€8.0M€42.5M€7.1M€4.4M€9.9M€10.9M
Total current assets€62.8M€61.5M€87.3M€52.4M€93.1M€125.2M€46.1M€42.7M€53.1M€26.9M
Property, plant & equipment (net)€4.6M€5.5M€6.1M€7.1M€8.2M€8.3M€9.4M€2.9M€3.0M€2.4M
Goodwill & intangible assets€10,000€7,000€8,000€1,000€4,000€21,000€163,000€102,000€135,968€4,453
Long-term investments€0€0€0€0€98,000€105,000€131,000€176,000€0€0
Other non-current assets€434,000€407,000€443,000€290,000€421,000€400,000€398,000€382,000€1.2M€1.1M
Total assets€67.8M€67.4M€93.9M€59.8M€101.8M€134.0M€56.2M€46.2M€57.5M€30.4M
Liabilities
Accounts payable€6.6M€4.5M€6.7M€4.0M€5.0M€5.6M€6.2M€4.5M€5.1M€4.4M
Short-term debt€4.3M€4.9M€5.0M€4.6M€8.2M€4.9M€1.1M€407,000€770,000€1.1M
Deferred revenue€36.2M€18.2M€18.2M€16.6M€16.8M€8.6M€7.1M€93,000€3.0M€2.2M
Total current liabilities€57.5M€58.9M€49.9M€37.9M€36.8M€19.0M€14.3M€11.6M€9.4M€8.2M
Long-term debt€89.1M€43.0M€41.7M€44.0M€32.4M€39.1M€37.6M€20.0M€4.0M€4.6M
Lease obligations€3.1M€4.2M€5.1M€5.5M€6.5M€6.2M€6.4M———
Other long-term liabilities€5.6M€31.2M€4.2M€4.8M€5.7M€5.4M€6.1M€334,000€233,467€175,207
Total liabilities€152.2M€133.1M€95.7M€86.8M€75.0M€63.6M€58.1M€32.0M€13.5M€13.0M
Shareholders' equity
Common stock & paid-in capital€1.5M€1.4M€1.4M€1.0M€1.0M€1.0M€672,000€589,000€589,000€478,958
Retained earnings (deficit)−€24.0M−€68.1M−€39.7M−€57.0M−€47.0M−€33.6M−€50.9M−€30.3M−€26.1M−€21.9M
Accumulated other comprehensive income−€376.1M−€311.5M−€276.1M−€226.6M−€182.8M−€152.5M−€104.6M−€78.7M−€54.3M−€35.4M
Total shareholders' equity−€84.5M−€65.7M−€1.8M−€27.0M€26.8M€70.5M−€1.9M€14.2M€43.9M€17.4M
Key figures
Total debt€95.3M€50.9M€50.6M€53.2M€46.0M€49.0M€44.5M€20.5M€4.7M€5.7M
Net cash (debt)−€42.6M−€1.2M€24.7M−€11.8M€38.1M€70.2M−€9.4M€15.7M€42.5M€15.4M
Working capital€5.2M€2.5M€37.5M€14.4M€56.2M€106.2M€31.8M€31.1M€43.8M€18.6M
Tangible book value−€84.5M−€65.7M−€1.9M−€27.0M€26.8M€70.4M−€2.1M€14.1M€43.8M€17.4M
Shares outstanding47.8M47.3M36.9M34.9M34.7M24.4M21.6M19.6M17.5M15.3M
Current ratio1.091.041.751.382.536.583.223.685.683.26
Quick ratio1.050.991.571.172.396.462.533.215.142.55
Debt / equity————1.720.70—1.440.110.33
Equity / assets−124.7%−97.5%−2.0%−45.2%26.3%52.6%−3.4%30.8%76.4%57.2%

Quarterly columns are labeled by the month the quarter ended. Figures in euros as reported (latest annual report filed March 31, 2026); data from EODHD.

NBTX financial position

At the end of fiscal 2025 (December 31, 2025), Nanobiotix had total assets of €67.8 million (up 0.5% from a year earlier), total liabilities of €152.2 million and shareholders' equity of -€84.5 million. It held €52.8 million in cash and short-term investments against €95.3 million of debt, net debt of €42.6 million. Its current ratio was 1.09. In the latest quarter (ended June 30, 2026) total assets were €128.3 million and equity -€33.4 million.

Related: NBTX income statement, NBTX cash flow statement, NBTX key metrics. See the NBTX stock overview for the latest quote and news.

NBTX balance sheet FAQ

What are Nanobiotix's total assets?

Nanobiotix reported total assets of €67.8 million at the end of fiscal 2025 (December 31, 2025), compared with €67.4 million a year earlier.

How much debt does Nanobiotix have?

Nanobiotix had €95.3 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was —.

How much cash does Nanobiotix have?

Nanobiotix held €52.8 million in cash and short-term investments at the end of fiscal 2025; with €95.3 million of debt that is net debt of €42.6 million.

What is Nanobiotix's book value?

Nanobiotix's shareholders' equity (book value) was -€84.5 million at the end of fiscal 2025.

What is Nanobiotix's current ratio?

Nanobiotix had current assets of €62.8 million and current liabilities of €57.5 million, a current ratio of 1.09 (it can cover its short-term obligations).

How much goodwill does Nanobiotix have?

Nanobiotix carried €0.0 million of goodwill and intangible assets, 0.0% of total assets, at the end of fiscal 2025.

Biotechnology: balance sheet